SPACInsider Logo
Artisan Acquisition Corp. (ARTA) Shareholders Approve Prenetics Deal
by Marlena Haddad on 2022-05-10 at 8:20am

Artisan (NASDAQ:ARTA) announced this afternoon that its shareholders have voted to approve its combination with genomic and diagnostic testing company Prenetics Group Limited in a special meeting held yesterday.

Although today’s 8-K filing did not disclose redemption numbers, ARTA traded above its trust value throughout its redemption deadline May 5, and saw a high of $10.10 yesterday.

A total of 28,205,766, or 64.22%, of Artisan’s issued and outstanding ordinary shares were present at yesterday’s special meeting. The business combination was overwhelmingly approved with 27,309,556 votes in favor of the transaction, and just 895,867 against it.

The SPAC recently made several amendments to the deal which covered a range of agreements, including the business combination, the sponsor agreement, the PIPE subscription, deeds of novation and forward purchase agreements (FPA), the sponsor agreement, and the shareholder support agreement.

The parties expect to close the deal on Wednesday, May 18, 2022. The combined company’s shares and warrants are expected to begin trading on the Nasdaq Stock Market under the symbols “PRE” and “PRENW,” respectively, on Wednesday, May 18, 2022.

Artisan initially announced its $1.25 billion combination with Prenetics on September 15, 2021. Hong Kong-based Prenetics is a global leader in genomic and diagnostic testing that is decentralizing healthcare with a focus on prevention, diagnostics and personalized care.


  • UBS Securities LLC is acting as sole financial advisor and exclusive capital markets advisor to Artisan.
  • Citigroup Global Markets Asia Limited is acting as sole financial advisor to Prenetics.
  • UBS Securities LLC, Citigroup Global Markets Inc., Credit Suisse Securities (USA) LLC and China International Capital Corporation Hong Kong Securities Limited are serving as placement agents on the PIPE.
  • Skadden, Arps, Slate, Meagher & Flom LLP is serving as international legal counsel, and Mourant is serving as Cayman legal counsel, to Prenetics.
  • Kirkland & Ellis LLP is serving as international legal counsel, and Appleby is serving as Cayman legal counsel, to Artisan.
  • Shearman & Sterling LLP is serving as international counsel to the placement agents.
  • KPMG LLP is serving as the auditor to Prenetics.
Recent Posts
by Kristi Marvin on 2023-03-25 at 12:14pm

Terms Tracker for the Week Ending March 24, 2023 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. While this week was relatively quiet on the filings front, we did see March’s second SPAC IPO price with Oak Woods Acquisition Corp’s $50 million...

by Marlena Haddad on 2023-03-24 at 5:40pm

Latest Non-Redemption Agreements: ExcelFin Acquisition Corp. ExcelFin Acquisition Corp. (XFIN) Adds Non-Redemption Agreement In connection with the special meeting of stockholders of ExcelFin Acquisition Corp. (NASDAQ:XFIN) to extend its completion deadline from April 25, 2023 to October 25, 2023, the company and its sponsor, ExcelFin SPAC LLC, entered into a non-redemption agreement with an unaffiliated third party....

by Marlena Haddad on 2023-03-24 at 11:33am

Below is a daily summary of links to the latest SPAC news and rumors gathered across the web.  Latest SPAC News:  Momentus SPAC backers accused of deliberately engineering a catastrophic deal  Momentus SPAC Backers Accused of Hiding Disastrous Deal’s Flaws A Momentus Inc. (NASDAQ:MNTS) investor sued backers of its blank-check merger with a shell company,...

by Nicholas Alan Clayton on 2023-03-24 at 7:20am

DiamondHead Holdings Corp. (NASDAQ:DHHC) announced in an 8-K this morning that its shareholders approved its combination with Great Southern Homes at a special meeting March 23. Only 109,426 shares were redeemed in the connection with the vote, but DiamondHead has seen about 87% redemptions in total across all previous votes, leaving it with about $43.9...

by Nicholas Alan Clayton on 2023-03-24 at 7:05am

Graf Acquisition Corp. IV (NYSE:GFOR) announced that it has signed a non-binding letter of intent to combine with clinical-stage biopharma company NKGen. This announcement is not a pure teaser as Graf IV is not facing an imminent extension vote and currently has until May 25 on its clock. It does, however, signal something of a...

Privacy Policy|Terms Of Use
Copyright © 2023 SPACInsider, Inc. All Rights Reserved